Task: Answer the multiple-choice question.
Query: Which drug exhibits a 5.717\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CN(C)CCCN1C(=O)C2CCc3[nH]c4ccccc4c3C2C1=O
[b] CC(C)C(=O)Nc1c2c(nc3c1CCC3)CCCC2
[c] CCN1CCN(c2ccc(S(=O)(=O)N3CCOCC3)cc2NC(=O)CC(C)C)CC1
[d] Cc1cc(C)cc(N2C(=O)NC(=O)/C(=C\c3cccn3-c3ccc(Cl)cc3)C2=O)c1
[e] COc1ccc(-c2noc(CSc3ccccc3)n2)cc1OC
Answer: c. CCN1CCN(c2ccc(S(=O)(=O)N3CCOCC3)cc2NC(=O)CC(C)C)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2ccc(S(=O)(=O)N3CCOCC3)cc2NC(=O)CC(C)C)CC1
CCN1CCN(c2ccc(S(=O)(=O)N3CCOCC3)cc2NC(=O)CC(C)C)CC1
N-[2-(4-ethylpiperazin-1-yl)-5-morpholin-4-ylsulfonylphenyl]-3-methylbutanamide